ST Pharm Statistics

Total Valuation

ST Pharm has a market cap or net worth of KRW 1.51 trillion. The enterprise value is 1.51 trillion.

Market Cap	1.51T
Enterprise Value	1.51T

Important Dates

The next estimated earnings date is Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

ST Pharm has 20.15 million shares outstanding. The number of shares has increased by 1.91% in one year.

Current Share Class	n/a
Shares Outstanding	20.15M
Shares Change (YoY)	+1.91%
Shares Change (QoQ)	-0.74%
Owned by Insiders (%)	7.81%
Owned by Institutions (%)	12.48%
Float	12.38M

Valuation Ratios

The trailing PE ratio is 42.13 and the forward PE ratio is 32.55. ST Pharm's PEG ratio is 0.56.

PE Ratio	42.13
Forward PE	32.55
PS Ratio	5.34
PB Ratio	3.00
P/TBV Ratio	3.11
P/FCF Ratio	56.72
P/OCF Ratio	n/a
PEG Ratio	0.56

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.45, with an EV/FCF ratio of 56.62.

EV / Earnings	43.46
EV / Sales	5.51
EV / EBITDA	28.45
EV / EBIT	54.96
EV / FCF	56.62

Financial Position

The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.23.

Current Ratio	2.48
Quick Ratio	1.43
Debt / Equity	0.23
Debt / EBITDA	2.22
Debt / FCF	4.43
Interest Coverage	3.58

Financial Efficiency

Return on equity (ROE) is 7.30% and return on invested capital (ROIC) is 2.88%.

Return on Equity (ROE)	7.30%
Return on Assets (ROA)	2.48%
Return on Invested Capital (ROIC)	2.88%
Return on Capital Employed (ROCE)	4.70%
Revenue Per Employee	417.94M
Profits Per Employee	53.00M
Employee Count	655
Asset Turnover	0.39
Inventory Turnover	1.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.81% in the last 52 weeks. The beta is 0.58, so ST Pharm's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-18.81%
50-Day Moving Average	81,480.00
200-Day Moving Average	91,480.50
Relative Strength Index (RSI)	32.51
Average Volume (20 Days)	96,264

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ST Pharm had revenue of KRW 273.75 billion and earned 34.71 billion in profits. Earnings per share was 1,780.00.

Revenue	273.75B
Gross Profit	93.60B
Operating Income	27.69B
Pretax Income	42.75B
Net Income	34.71B
EBITDA	53.27B
EBIT	27.69B
Earnings Per Share (EPS)	1,780.00

Full Income Statement

Balance Sheet

The company has 120.92 billion in cash and 118.14 billion in debt, giving a net cash position of 2.78 billion or 138.04 per share.

Cash & Cash Equivalents	120.92B
Total Debt	118.14B
Net Cash	2.78B
Net Cash Per Share	138.04
Equity (Book Value)	502.99B
Book Value Per Share	24,999.21
Working Capital	196.80B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 109.45 billion and capital expenditures -82.81 billion, giving a free cash flow of 26.65 billion.

Operating Cash Flow	109.45B
Capital Expenditures	-82.81B
Free Cash Flow	26.65B
FCF Per Share	1,322.17

Full Cash Flow Statement

Margins

Gross margin is 34.19%, with operating and profit margins of 10.12% and 12.68%.

Gross Margin	34.19%
Operating Margin	10.12%
Pretax Margin	15.62%
Profit Margin	12.68%
EBITDA Margin	19.46%
EBIT Margin	10.12%
FCF Margin	9.73%

Dividends & Yields

This stock pays an annual dividend of 500.00, which amounts to a dividend yield of 0.69%.

Dividend Per Share	500.00
Dividend Yield	0.69%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	27.09%
Buyback Yield	-1.91%
Shareholder Yield	-1.21%
Earnings Yield	2.30%
FCF Yield	1.76%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ST Pharm has an Altman Z-Score of 5.82.

Altman Z-Score	5.82
Piotroski F-Score	n/a